Combining chemotherapy with immunotherapy to treat mesothelioma: an investigation into the role of CD4+ T cells in a murine model

QR Code

Combining chemotherapy with immunotherapy to treat mesothelioma: an investigation into the role of CD4+ T cells in a murine model

Cytotoxic chemotherapy remains the mainstay of treatment for patients with cancer, however immunotherapy is starting to emerge as an additional modality of treatment. Evidence suggests that chemotherapy can synergise with immunotherapy to improve responses. Although CD8 T cells have been regarded...

Full description

Bibliographic Details
Main Author:	Steer, Henry John
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2013
Online Access:	https://eprints.nottingham.ac.uk/13672/

Similar Items

Murine mesothelioma induces locally-proliferating IL-10+TNF-a+CD206-CX3CR1+ M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy
by: Jackaman, Connie, et al.
Published: (2016)

Enhanced dendritic cell immunotherapy to treat glioblastoma
by: Adhikaree, Jason
Published: (2019)

Hypoxic Regions in Mesothelioma Likely Modulate Cross-Talk between Tumour Cells, Macrophages and Endothelial Cells and Regulate Responses to Immunotherapy
by: Alrehaily, Abdulwahed
Published: (2021)

Induction of apoptosis in murine malignant mesothelioma cell lines: gene expression and susceptibility
by: Kusmiaty
Published: (2003)

Comparison of rArt v 1-based sublingual and subcutaneous immunotherapy in a murine model of asthma
by: Tabynov, Kairat, et al.
Published: (2025)

CD40-activated B cells contribute to mesothelioma tumor regression
by: Jackaman, Connie, et al.
Published: (2011)

Characterisation of genes derived from murine malignant mesothelioma by suppression subtractive hybridization
by: Thean, Ai Lee
Published: (2002)

Inhibition of the p38 MAPK pathway in human CD1c+ Dendritic Cells enhances their function for cancer immunotherapy
by: Kaur, Aanchal Preet
Published: (2021)

Rapid copper acquisition by developing murine mesothelioma: Decreasing bioavailable copper slows tumor growth, normalizes vessels and promotes T cell infiltration
by: Crowe, Andrew, et al.
Published: (2013)

Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy
by: Blaxill, J., et al.
Published: (2021)

Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo
by: Jackaman, Connie, et al.
Published: (2012)

Cancer immunotherapy: current progress and applications
by: Leong, Pooi Pooi, et al.
Published: (2006)

Combination effect of photodynamic therapy (pdt) and chemotherapy on oral cancer cell lines
by: Teoh, Jia Jie
Published: (2012)

IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase
by: Jackaman, Connie, et al.
Published: (2012)

Curcumin combination chemotherapy: the implication and efficacy in cancer
by: Tan, Bee Ling, et al.
Published: (2019)

MESOTHELIOMA IN AUSTRALIA-RESULTS FROM THE AUSTRALIAN MESOTHELIOMA REGISTRY
by: Sim, M., et al.
Published: (2016)

Structural glycobiology of antibody recognition in xenotransplantation and cancer immunotherapy
by: Agostino, Mark, et al.
Published: (2012)

Studies on the Effect of Aging and Mesothelioma on Dendritic Cell Subsets
by: Cornwall, Scott M.J.
Published: (2015)

Infectivity of CD4+ T cells and CD8+ T cells against IBDV in chicken
by: Teoh, Siak Mun, et al.
Published: (2015)

Mechanisms of cisplatin-induced cell death in malignant mesothelioma cells: Role of inhibitor of apoptosis proteins (IAPs) and caspases
by: Cregan, I., et al.
Published: (2013)

Palliative care in mesothelioma
by: Brims, Fraser
Published: (2018)

The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment
by: Nelson, Delia, et al.
Published: (2014)

Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function
by: Gardner, J., et al.
Published: (2015)

Intratumoral interleukin-2/agonist CD40 antibody drives CD4+ - independent resolution of treated-turmors and CD4+ -dependent systemic and memory responses
by: Jackaman, Connie, et al.
Published: (2012)

Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses
by: Jackaman, Connie, et al.
Published: (2012)

An increase in suppressive dendritic cells and T cells is a hallmark of healthy aging, a phenomenon exacerbated by cancer and modulated by chemo‐ and immunotherapy
by: Gardner, Joanne Karina
Published: (2016)

Emerging Mechanisms of Physical Exercise Benefits in Adjuvant and Neoadjuvant Cancer Immunotherapy.
by: Casciano, Fabio, et al.
Published: (2024)

Advances in therapeutic cancer vaccines, their obstacles, and prospects toward tumor immunotherapy
by: Eskandari, Azadeh, et al.
Published: (2024)

Henoch-Schonlein purpura in mesothelioma
by: Joshi, S., et al.
Published: (2014)

Wnt Signalling in Malignant Mesothelioma
by: Richards, Alexander S.K.
Published: (2016)

Mesothelioma in australia: A review
by: Musk, A., et al.
Published: (2017)

Predicting survival in malignant mesothelioma
by: Musk, A., et al.
Published: (2011)

Ageing and Mesothelioma Drive Lipid Accumulation and Dysfunction in Dendritic Cells and Macrophages
by: Sheeraz, Mohd
Published: (2022)

Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells
by: Fox, Simon, et al.
Published: (2013)

Epidemiology of Malignant Pleural Mesothelioma in Australia
by: De Klerk, N., et al.
Published: (2016)

Prognostic factors for malignant pleural mesothelioma
by: Brims, Fraser, et al.
Published: (2013)

Predicting the parasite killing effect of artemisinin combination therapy in a murine malaria model
by: Patel, K., et al.
Published: (2014)

Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells
by: Perumal, Vanathi, et al.
Published: (2015)

The anticancer effect of local vernonia amygdalina in combination with standard chemotherapy drug, tamoxifen on breast cancer cell line, MCF-7
by: Jian, Chin Tze
Published: (2018)

Investigation the role of CD24 in metastatic colorectal cancer
by: Alsulaiman, Abdullah
Published: (2018)